weeks in addition to the thiazide treatment. Compliance was determined by weekly pill counts. Blood pressure, heart rate, and body weight were measured weekly in the outpatient clinic after 15 minutes recumbent in standard conditions in the late afternoon. Duplicate measurements of blood pressure were performed weekly using a random zero sphygmomanometer (Hawksley and Sons Ltd, Lancing). Measurements, including body weight, taken during the second, third, and fourth week of the indomethacin treatment were compared with those obtained during treatment with sulindac and with similar data from the run-in period. Statistical significance was determined by the Wilcoxon test for paired differences.
Body weight increased by 1 kg during treatment with indomethacin when compared with during sulindac treatment or the run-in period (p < 0-02) . No changes were observed during treatment with sulindac. Supine and erect blood pressure increased significantly during treatment with indomethacin as compared to during treatment with sulindac ( figure) . Sulindac, however, significantly enhanced the antihypertensive effect of thiazides when blood pressure during treatment is compared with that during the run-in period: indomethacin tended to attenuate this antihypertensive effect in the same patients (figure). 
Chloroquine-associated pruritus in a European
Pruritus occurring after ingestion of chloroquine for chemotherapy or chemoprophylaxis of malaria is a toxic reaction commonly encountered in Africans.'-3 To our knowledge this reaction has not previously been described in a European.
Case report
A 23-year-old white British nurse who was working in a rural, holoendemically malarious area of Kenya was taking dapsone 100 mg and pyrimethamine 12-5 mg (Maloprim) weekly on an irregular basis for malaria chemoprophylaxis. She developed a high temperature and shaking chills. Because of the history of exposure to malaria, the absence of diagnostic facilities, the lack of signs or symptoms suggestive of other diagnoses, and the fact that she had previously had a similar attack, when malaria had been confirmed, presumptive treatment with chloroquine phosphate was begun. She was given chloroquine by mouth, 600 mg base initially and then 300 mg base at eight, 24, and 48 hours. The first tablets were ingested at about 10 00 and the second dose at 1800 the same day. Early next morning she awoke with severe itching over her entire body, particularly her palms and the soles of her feet. She was unable to sleep and described the itching as being deep "under the skin" and that "there was no way to relieve it."
She was examined that morning, when there were no abnormal physical signs except scratch marks. The temperature and chills disappeared within 24 hours and did not recur. Although itching continued for about 55 hours, it did not increase after the dose of chloroquine at 24 hours and it lessened before the last dose at 48 hours. Antihistamines were given without apparent effect. She felt nauseated throughout the treatment but did not vomit; she was not taking any other drugs. Tablets from the tin from which her course had been taken were not analysed; however, randomly selected chloroquine phosphate tablets from other tins purchased from the same manufacturer at the same time were examined by Dr F C Churchill, at the Centers for Disease Control, Atlanta, Georgia, USA, using high-pressure liquid chromatography. The tablets contained the expected amount of chloroquine phosphate and had no obvious impurities. One of us was taking tablets for malaria chemoprophylaxis from the same tin without untoward effects. In 1974 the patient had taken 600 mg chloroquine phosphate base for malaria without itching.
Comment
The symptoms observed in this European patient were identical with those previously reported in chloroquine-associated pruritus in Africans.'-3 Generally, the patient has taken chloroquine before; symptoms begin six to 48 hours after ingestion of the drug; and pruritus affects the entire body but particularly the palms, soles, and scalp. A rash is not present, and there are no other associated signs or symptoms. There is no relation between the occurrence of itching and the presence of malaria parasites in the blood. The sensation is often severe enough to be incapacitating, and frank psychosis may develop. Patients are generally unwilling to take chloroquine again. Itching has been reported after ingestion of other chloroquine salts as well as chloroquine phosphate and occurs after intramuscular injection as well as oral administration. The syndrome has been reported after ingestion of chloroquine for chemoprophylaxis and for single-dose (10 mg base/kg) and triple-dose (25 mg base/kg) treatment. The mechanism is unknown, but treatment with antihistamines is reported to be ineffective.
The reported incidence of chloroquine-associated pruritus in An 87-year-old woman with no previous medical history of note was admitted to hospital with acute breathlessness. On examination the patient was severely unwell and dyspnoeic. Pulse was 150/min, blood pressure 180/60 mm Hg, and jugular vein pulse was raised at 6 cm. Heart sounds were normal, and the apex beat was palpable in the anterior axillary line. Air entry was diminished over the right lung and stridor was present. A portable chest x-ray film (figure) showed a dilated gas-filled structure extending, from the mediastinum to the level of the larynx. Indirect laryngoscopy was performed and a large retropharyngeal swelling at the level of the arytenoid cartilages was evident, pushing the larynx forward. During the procedure the patient's condition deteriorated further. As an emergency measure a cardiac needle was pushed into the mass and about 50 ml of air was aspirated. The patient's condition improved dramatically. She then underwent rigid bronchoscopy, which showed no abnormality apart from copious secretions, which were aspirated.
An emergency barium swallow showed the oesophagus to be hugely dilated proximally with an apparent stricture about 11 cm from the cardia. At fibreoptic oesophagoscopy there was a large collection of food and fluid in the oesophagus but no stricture, and the endoscope passed readily through the cardia into the stomach. The appearances were characteristic of achalasia of the cardia and findings of further barium studies supported this diagnosis. It then became apparent that she had had dysphagia for some months and was unable to swallow liquids. Rider-Moeller bag dilatation of the lower sphincteric ring was therefore undertaken on two occasions. Initially, her general condition and dysphagia improved, but she subsequently developed bronchopneumonia and died eight weeks from the time of presentation.
At necropsy the respiratory system showed severe bronchopneumonia with patchy consolidation of both lower lobes. In the alimentary system the oesophagtis was widely dilated in its upper two thirds and contained food and fluid. The lower third was narrowed and showed no evidence of ulceration or malignancy.
Chest x-ray film before decompression showing the dilated oesophagus and also shift of mediastinum to left.
McLean et al supplied an explanation of the mechanism whereby the oesophagus becomes dilated to the extent that it impinges on the larynx and is able to distort the posterior membranous portion of the trachea, giving rise to features of obstruction of the upper airway.' They contend that the cricopharyngeal muscle that normally prevents air swallowing may malfunction to the extent that air swallowing is facilitated while escape of swallowed air is prevented. Consequently, the oesophagus dilates hugely and compresses neighbouring structures: depending on the extent of oesophageal dilatation there may also be signs of obstruction of the thoracic inlet. Decompression of the oesophagus results in a dramatic relief of symptoms. Previously this has been achieved by emergency oesophagoscopy. ' Treatment by needle aspiration of the oesophagus has not previously been described and may be lifesaving if emergency oesophagoscopy is not available. 
